CVS Health Corp (CVS)
57.10
+0.27
(+0.48%)
USD |
NYSE |
Nov 21, 16:00
57.10
0.00 (0.00%)
After-Hours: 20:00
CVS Health Enterprise Value: 127.87B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 127.87B |
| November 20, 2024 | 127.53B |
| November 19, 2024 | 126.20B |
| November 18, 2024 | 126.55B |
| November 15, 2024 | 122.95B |
| November 14, 2024 | 125.34B |
| November 13, 2024 | 124.31B |
| November 12, 2024 | 124.01B |
| November 11, 2024 | 126.25B |
| November 08, 2024 | 125.91B |
| November 07, 2024 | 127.83B |
| November 06, 2024 | 133.55B |
| November 05, 2024 | 125.66B |
| November 04, 2024 | 124.79B |
| November 01, 2024 | 126.25B |
| October 31, 2024 | 127.07B |
| October 30, 2024 | 126.98B |
| October 29, 2024 | 126.78B |
| October 28, 2024 | 128.17B |
| October 25, 2024 | 127.08B |
| October 24, 2024 | 126.61B |
| October 23, 2024 | 127.45B |
| October 22, 2024 | 127.53B |
| October 21, 2024 | 129.19B |
| October 18, 2024 | 131.92B |
| Date | Value |
|---|---|
| October 17, 2024 | 136.11B |
| October 16, 2024 | 137.81B |
| October 15, 2024 | 137.79B |
| October 14, 2024 | 140.88B |
| October 11, 2024 | 139.84B |
| October 10, 2024 | 140.11B |
| October 09, 2024 | 139.01B |
| October 08, 2024 | 138.92B |
| October 07, 2024 | 138.10B |
| October 04, 2024 | 137.27B |
| October 03, 2024 | 135.17B |
| October 02, 2024 | 134.31B |
| October 01, 2024 | 133.43B |
| September 30, 2024 | 135.12B |
| September 27, 2024 | 127.51B |
| September 26, 2024 | 124.53B |
| September 25, 2024 | 124.06B |
| September 24, 2024 | 123.36B |
| September 23, 2024 | 122.71B |
| September 20, 2024 | 122.64B |
| September 19, 2024 | 123.76B |
| September 18, 2024 | 123.78B |
| September 17, 2024 | 123.04B |
| September 16, 2024 | 123.72B |
| September 13, 2024 | 123.23B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
118.56B
Minimum
May 28 2024
189.42B
Maximum
Feb 08 2022
149.16B
Average
147.29B
Median
Enterprise Value Benchmarks
| Humana Inc | 24.54B |
| Eli Lilly and Co | 739.59B |
| Walgreens Boots Alliance Inc | 15.35B |
| SCWorx Corp | 3.411M |
| AirSculpt Technologies Inc | 456.61M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 87.00M |
| Revenue (Quarterly) | 95.43B |
| Total Expenses (Quarterly) | 93.43B |
| EPS Diluted (Quarterly) | 0.07 |
| Gross Profit Margin (Quarterly) | 13.16% |
| Profit Margin (Quarterly) | 0.09% |
| Earnings Yield | 6.90% |
| Operating Earnings Yield | 14.75% |
| Normalized Earnings Yield | 7.999 |